The global Biomarker-based Immunoassay market was valued at US$ 3857 million in 2025 and is anticipated to reach US$ 5647 million by 2032, at a CAGR of 5.6% from 2026 to 2032.

Biomarker-based Immunoassay Market

Biomarker-based immunoassay is a diagnostic technology built upon the specific antigen–antibody binding principle to detect and quantify biomarkers such as proteins, peptides, hormones, cytokines, and tumor markers in biological samples including blood, urine, saliva, or tissues. It enables disease screening, diagnostic stratification, therapeutic monitoring, and prognosis evaluation. Widely applied in oncology, cardiovascular diseases, autoimmune disorders, infectious diseases, and neurological conditions, this technology is characterized by high sensitivity, high specificity, and advanced automation. With the advancement of precision medicine and personalized healthcare, biomarker-based immunoassays are evolving from single-analyte detection toward multiplex testing, digital analytics, and intelligent integration, forming a core technological platform in modern clinical diagnostics and the in vitro diagnostics industry chain. The average gross profit margin of this product is 45%.

Driven by the global expansion of precision medicine and molecular stratification strategies, biomarker-based immunoassays have become essential tools for early disease screening and targeted therapy selection. Growing demand for oncology early detection, companion diagnostics, and chronic disease management continues to stimulate technological innovation toward higher sensitivity and multiplex capability. Healthcare infrastructure upgrades and tiered medical systems are accelerating penetration of automated immunoassay platforms in secondary and primary care institutions. The integration of digital healthcare and artificial intelligence enables multi-biomarker analysis, enhancing clinical decision-making value. In addition, global population aging further expands demand for oncology, cardiovascular, and metabolic disease diagnostics, creating long-term structural growth momentum.

The industry faces challenges including high technological barriers, long development cycles, and stringent clinical validation requirements. Dependence on imported high-end reagents and critical raw materials increases vulnerability to global supply chain fluctuations. Meanwhile, multiple technology platforms such as chemiluminescence, ELISA, and fluorescence-based systems compete intensely, leading to product homogenization and pricing pressure. Regulatory frameworks for in vitro diagnostics are becoming increasingly stringent worldwide, raising compliance and approval costs, particularly affecting small and mid-sized enterprises.

Downstream demand is shifting from single-analyte testing toward multiplex and panel-based approaches, particularly in tumor markers and inflammatory biomarkers, where combined risk modeling is gaining clinical importance. Hospitals are increasingly demanding fully automated and integrated systems with high throughput and data connectivity capabilities. Independent clinical laboratories and chain-based health screening institutions are driving demand for standardized and scalable reagent solutions. At the same time, home-based testing and point-of-care applications are emerging, promoting the development of compact and portable immunoassay systems, resulting in a dual in-hospital and out-of-hospital market structure.

Key upstream materials include high-purity antibodies, recombinant antigens, enzyme labels, magnetic microbeads, chemiluminescent substrates, and optimized biological buffer systems. High-affinity monoclonal antibodies and recombinant proteins are critical determinants of assay sensitivity and specificity, requiring advanced technical capabilities. Improvements in magnetic particle and nanomaterial technologies contribute to signal amplification efficiency. In addition, automated analyzers rely on precision optical detection modules and fluidic systems. Overall, the upstream segment is technology-intensive and relatively concentrated, with ongoing localization efforts in core materials while high-end components remain strategically significant.

This report delivers a comprehensive overview of the global Biomarker-based Immunoassay market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Biomarker-based Immunoassay. The Biomarker-based Immunoassay market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Biomarker-based Immunoassay market comprehensively. Regional market sizes by Type, by Application, by Sample, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Biomarker-based Immunoassay manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Biomarker-based Immunoassay Market Report

Report Metric	Details
Report Name	Biomarker-based Immunoassay Market
Accounted market size in 2025	US$ 3857 million
Forecasted market size in 2032	US$ 5647 million
CAGR	5.6%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Reagents & Kits Instruments/Analyzers Others
Segment by Sample	Blood Tissue Urine Others
Segment by Disease	Cancer Cardiovascular Neurological Others
Segment by Application	Hospital Third-party Laboratory Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Sysmex, BioMerieux, QuidelOrtho, Becton Dickinson, Bio-Rad Laboratories, Qiagen, Wuhan Easy Diagnosis, Wondfo, KHB, Mindray, Getein Biotech, Daan Gene
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Sample, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Biomarker-based Immunoassay companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Biomarker-based Immunoassay Market growing?

Ans: The Biomarker-based Immunoassay Market witnessing a CAGR of 5.6% during the forecast period 2026-2032.

What is the Biomarker-based Immunoassay Market size in 2032?

Ans: The Biomarker-based Immunoassay Market size in 2032 will be US$ 5647 million.

Who are the main players in the Biomarker-based Immunoassay Market report?

Ans: The main players in the Biomarker-based Immunoassay Market are Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Sysmex, BioMerieux, QuidelOrtho, Becton Dickinson, Bio-Rad Laboratories, Qiagen, Wuhan Easy Diagnosis, Wondfo, KHB, Mindray, Getein Biotech, Daan Gene

What are the Application segmentation covered in the Biomarker-based Immunoassay Market report?

Ans: The Applications covered in the Biomarker-based Immunoassay Market report are Hospital, Third-party Laboratory, Other

What are the Type segmentation covered in the Biomarker-based Immunoassay Market report?

Ans: The Types covered in the Biomarker-based Immunoassay Market report are Reagents & Kits, Instruments/Analyzers, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biomarker-based Immunoassay Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Reagents & Kits

1.2.3 Instruments/Analyzers

1.2.4 Others

1.3 Market by Sample

1.3.1 Global Biomarker-based Immunoassay Market Size Growth Rate by Sample: 2021 vs 2025 vs 2032

1.3.2 Blood

1.3.3 Tissue

1.3.4 Urine

1.3.5 Others

1.4 Market by Disease

1.4.1 Global Biomarker-based Immunoassay Market Size Growth Rate by Disease: 2021 vs 2025 vs 2032

1.4.2 Cancer

1.4.3 Cardiovascular

1.4.4 Neurological

1.4.5 Others

1.5 Market by Application

1.5.1 Global Biomarker-based Immunoassay Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Hospital

1.5.3 Third-party Laboratory

1.5.4 Other

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Biomarker-based Immunoassay Market Perspective (2021–2032)

2.2 Global Biomarker-based Immunoassay Growth Trends by Region

2.2.1 Global Biomarker-based Immunoassay Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Biomarker-based Immunoassay Historic Market Size by Region (2021–2026)

2.2.3 Biomarker-based Immunoassay Forecasted Market Size by Region (2027–2032)

2.3 Biomarker-based Immunoassay Market Dynamics

2.3.1 Biomarker-based Immunoassay Industry Trends

2.3.2 Biomarker-based Immunoassay Market Drivers

2.3.3 Biomarker-based Immunoassay Market Challenges

2.3.4 Biomarker-based Immunoassay Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Biomarker-based Immunoassay Players by Revenue

3.1.1 Global Top Biomarker-based Immunoassay Players by Revenue (2021–2026)

3.1.2 Global Biomarker-based Immunoassay Revenue Market Share by Players (2021–2026)

3.2 Global Top Biomarker-based Immunoassay Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Biomarker-based Immunoassay Revenue

3.4 Global Biomarker-based Immunoassay Market Concentration Ratio

3.4.1 Global Biomarker-based Immunoassay Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biomarker-based Immunoassay Revenue in 2025

3.5 Global Key Players of Biomarker-based Immunoassay Head Offices and Areas Served

3.6 Global Key Players of Biomarker-based Immunoassay, Products and Applications

3.7 Global Key Players of Biomarker-based Immunoassay, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Biomarker-based Immunoassay Breakdown Data by Type

4.1 Global Biomarker-based Immunoassay Historic Market Size by Type (2021–2026)

4.2 Global Biomarker-based Immunoassay Forecasted Market Size by Type (2027–2032)

5 Biomarker-based Immunoassay Breakdown Data by Application

5.1 Global Biomarker-based Immunoassay Historic Market Size by Application (2021–2026)

5.2 Global Biomarker-based Immunoassay Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Biomarker-based Immunoassay Market Size (2021–2032)

6.2 North America Biomarker-based Immunoassay Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Biomarker-based Immunoassay Market Size by Country (2021–2026)

6.4 North America Biomarker-based Immunoassay Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Biomarker-based Immunoassay Market Size (2021–2032)

7.2 Europe Biomarker-based Immunoassay Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Biomarker-based Immunoassay Market Size by Country (2021–2026)

7.4 Europe Biomarker-based Immunoassay Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Biomarker-based Immunoassay Market Size (2021–2032)

8.2 Asia-Pacific Biomarker-based Immunoassay Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Biomarker-based Immunoassay Market Size by Region (2021–2026)

8.4 Asia-Pacific Biomarker-based Immunoassay Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Biomarker-based Immunoassay Market Size (2021–2032)

9.2 Latin America Biomarker-based Immunoassay Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Biomarker-based Immunoassay Market Size by Country (2021–2026)

9.4 Latin America Biomarker-based Immunoassay Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Biomarker-based Immunoassay Market Size (2021–2032)

10.2 Middle East & Africa Biomarker-based Immunoassay Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Biomarker-based Immunoassay Market Size by Country (2021–2026)

10.4 Middle East & Africa Biomarker-based Immunoassay Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Biomarker-based Immunoassay Introduction

11.1.4 Roche Revenue in Biomarker-based Immunoassay Business (2021–2026)

11.1.5 Roche Recent Development

11.2 Abbott

11.2.1 Abbott Company Details

11.2.2 Abbott Business Overview

11.2.3 Abbott Biomarker-based Immunoassay Introduction

11.2.4 Abbott Revenue in Biomarker-based Immunoassay Business (2021–2026)

11.2.5 Abbott Recent Development

11.3 Danaher

11.3.1 Danaher Company Details

11.3.2 Danaher Business Overview

11.3.3 Danaher Biomarker-based Immunoassay Introduction

11.3.4 Danaher Revenue in Biomarker-based Immunoassay Business (2021–2026)

11.3.5 Danaher Recent Development

11.4 Siemens Healthineers

11.4.1 Siemens Healthineers Company Details

11.4.2 Siemens Healthineers Business Overview

11.4.3 Siemens Healthineers Biomarker-based Immunoassay Introduction

11.4.4 Siemens Healthineers Revenue in Biomarker-based Immunoassay Business (2021–2026)

11.4.5 Siemens Healthineers Recent Development

11.5 Thermo Fisher Scientific

11.5.1 Thermo Fisher Scientific Company Details

11.5.2 Thermo Fisher Scientific Business Overview

11.5.3 Thermo Fisher Scientific Biomarker-based Immunoassay Introduction

11.5.4 Thermo Fisher Scientific Revenue in Biomarker-based Immunoassay Business (2021–2026)

11.5.5 Thermo Fisher Scientific Recent Development

11.6 Sysmex

11.6.1 Sysmex Company Details

11.6.2 Sysmex Business Overview

11.6.3 Sysmex Biomarker-based Immunoassay Introduction

11.6.4 Sysmex Revenue in Biomarker-based Immunoassay Business (2021–2026)

11.6.5 Sysmex Recent Development

11.7 BioMerieux

11.7.1 BioMerieux Company Details

11.7.2 BioMerieux Business Overview

11.7.3 BioMerieux Biomarker-based Immunoassay Introduction

11.7.4 BioMerieux Revenue in Biomarker-based Immunoassay Business (2021–2026)

11.7.5 BioMerieux Recent Development

11.8 QuidelOrtho

11.8.1 QuidelOrtho Company Details

11.8.2 QuidelOrtho Business Overview

11.8.3 QuidelOrtho Biomarker-based Immunoassay Introduction

11.8.4 QuidelOrtho Revenue in Biomarker-based Immunoassay Business (2021–2026)

11.8.5 QuidelOrtho Recent Development

11.9 Becton Dickinson

11.9.1 Becton Dickinson Company Details

11.9.2 Becton Dickinson Business Overview

11.9.3 Becton Dickinson Biomarker-based Immunoassay Introduction

11.9.4 Becton Dickinson Revenue in Biomarker-based Immunoassay Business (2021–2026)

11.9.5 Becton Dickinson Recent Development

11.10 Bio-Rad Laboratories

11.10.1 Bio-Rad Laboratories Company Details

11.10.2 Bio-Rad Laboratories Business Overview

11.10.3 Bio-Rad Laboratories Biomarker-based Immunoassay Introduction

11.10.4 Bio-Rad Laboratories Revenue in Biomarker-based Immunoassay Business (2021–2026)

11.10.5 Bio-Rad Laboratories Recent Development

11.11 Qiagen

11.11.1 Qiagen Company Details

11.11.2 Qiagen Business Overview

11.11.3 Qiagen Biomarker-based Immunoassay Introduction

11.11.4 Qiagen Revenue in Biomarker-based Immunoassay Business (2021–2026)

11.11.5 Qiagen Recent Development

11.12 Wuhan Easy Diagnosis

11.12.1 Wuhan Easy Diagnosis Company Details

11.12.2 Wuhan Easy Diagnosis Business Overview

11.12.3 Wuhan Easy Diagnosis Biomarker-based Immunoassay Introduction

11.12.4 Wuhan Easy Diagnosis Revenue in Biomarker-based Immunoassay Business (2021–2026)

11.12.5 Wuhan Easy Diagnosis Recent Development

11.13 Wondfo

11.13.1 Wondfo Company Details

11.13.2 Wondfo Business Overview

11.13.3 Wondfo Biomarker-based Immunoassay Introduction

11.13.4 Wondfo Revenue in Biomarker-based Immunoassay Business (2021–2026)

11.13.5 Wondfo Recent Development

11.14 KHB

11.14.1 KHB Company Details

11.14.2 KHB Business Overview

11.14.3 KHB Biomarker-based Immunoassay Introduction

11.14.4 KHB Revenue in Biomarker-based Immunoassay Business (2021–2026)

11.14.5 KHB Recent Development

11.15 Mindray

11.15.1 Mindray Company Details

11.15.2 Mindray Business Overview

11.15.3 Mindray Biomarker-based Immunoassay Introduction

11.15.4 Mindray Revenue in Biomarker-based Immunoassay Business (2021–2026)

11.15.5 Mindray Recent Development

11.16 Getein Biotech

11.16.1 Getein Biotech Company Details

11.16.2 Getein Biotech Business Overview

11.16.3 Getein Biotech Biomarker-based Immunoassay Introduction

11.16.4 Getein Biotech Revenue in Biomarker-based Immunoassay Business (2021–2026)

11.16.5 Getein Biotech Recent Development

11.17 Daan Gene

11.17.1 Daan Gene Company Details

11.17.2 Daan Gene Business Overview

11.17.3 Daan Gene Biomarker-based Immunoassay Introduction

11.17.4 Daan Gene Revenue in Biomarker-based Immunoassay Business (2021–2026)

11.17.5 Daan Gene Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Thermo Fisher Scientific

List of Tables

Table 1. Global Biomarker-based Immunoassay Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Reagents & Kits

Table 3. Key Players of Instruments/Analyzers

Table 4. Key Players of Others

Table 5. Global Biomarker-based Immunoassay Market Size Growth Rate by Sample (US$ Million): 2021 vs 2025 vs 2032

Table 6. Key Players of Blood

Table 7. Key Players of Tissue

Table 8. Key Players of Urine

Table 9. Key Players of Others

Table 10. Global Biomarker-based Immunoassay Market Size Growth Rate by Disease (US$ Million): 2021 vs 2025 vs 2032

Table 11. Key Players of Cancer

Table 12. Key Players of Cardiovascular

Table 13. Key Players of Neurological

Table 14. Key Players of Others

Table 15. Global Biomarker-based Immunoassay Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 16. Global Biomarker-based Immunoassay Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Biomarker-based Immunoassay Market Size by Region (US$ Million), 2021–2026

Table 18. Global Biomarker-based Immunoassay Market Share by Region (2021–2026)

Table 19. Global Biomarker-based Immunoassay Forecasted Market Size by Region (US$ Million), 2027–2032

Table 20. Global Biomarker-based Immunoassay Market Share by Region (2027–2032)

Table 21. Biomarker-based Immunoassay Market Trends

Table 22. Biomarker-based Immunoassay Market Drivers

Table 23. Biomarker-based Immunoassay Market Challenges

Table 24. Biomarker-based Immunoassay Market Restraints

Table 25. Global Biomarker-based Immunoassay Revenue by Players (US$ Million), 2021–2026

Table 26. Global Biomarker-based Immunoassay Market Share by Players (2021–2026)

Table 27. Global Top Biomarker-based Immunoassay Players by Tier (Tier 1, Tier 2, and Tier 3), based on Biomarker-based Immunoassay Revenue, 2025

Table 28. Ranking of Global Top Biomarker-based Immunoassay Companies by Revenue (US$ Million) in 2025

Table 29. Global 5 Largest Players Market Share by Biomarker-based Immunoassay Revenue (CR5 and HHI), 2021–2026

Table 30. Global Key Players of Biomarker-based Immunoassay, Headquarters and Area Served

Table 31. Global Key Players of Biomarker-based Immunoassay, Products and Applications

Table 32. Global Key Players of Biomarker-based Immunoassay, Date of General Availability (GA)

Table 33. Mergers and Acquisitions, Expansion Plans

Table 34. Global Biomarker-based Immunoassay Market Size by Type (US$ Million), 2021–2026

Table 35. Global Biomarker-based Immunoassay Revenue Market Share by Type (2021–2026)

Table 36. Global Biomarker-based Immunoassay Forecasted Market Size by Type (US$ Million), 2027–2032

Table 37. Global Biomarker-based Immunoassay Revenue Market Share by Type (2027–2032)

Table 38. Global Biomarker-based Immunoassay Market Size by Application (US$ Million), 2021–2026

Table 39. Global Biomarker-based Immunoassay Revenue Market Share by Application (2021–2026)

Table 40. Global Biomarker-based Immunoassay Forecasted Market Size by Application (US$ Million), 2027–2032

Table 41. Global Biomarker-based Immunoassay Revenue Market Share by Application (2027–2032)

Table 42. North America Biomarker-based Immunoassay Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. North America Biomarker-based Immunoassay Market Size by Country (US$ Million), 2021–2026

Table 44. North America Biomarker-based Immunoassay Market Size by Country (US$ Million), 2027–2032

Table 45. Europe Biomarker-based Immunoassay Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Europe Biomarker-based Immunoassay Market Size by Country (US$ Million), 2021–2026

Table 47. Europe Biomarker-based Immunoassay Market Size by Country (US$ Million), 2027–2032

Table 48. Asia-Pacific Biomarker-based Immunoassay Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 49. Asia-Pacific Biomarker-based Immunoassay Market Size by Region (US$ Million), 2021–2026

Table 50. Asia-Pacific Biomarker-based Immunoassay Market Size by Region (US$ Million), 2027–2032

Table 51. Latin America Biomarker-based Immunoassay Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 52. Latin America Biomarker-based Immunoassay Market Size by Country (US$ Million), 2021–2026

Table 53. Latin America Biomarker-based Immunoassay Market Size by Country (US$ Million), 2027–2032

Table 54. Middle East & Africa Biomarker-based Immunoassay Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 55. Middle East & Africa Biomarker-based Immunoassay Market Size by Country (US$ Million), 2021–2026

Table 56. Middle East & Africa Biomarker-based Immunoassay Market Size by Country (US$ Million), 2027–2032

Table 57. Roche Company Details

Table 58. Roche Business Overview

Table 59. Roche Biomarker-based Immunoassay Product

Table 60. Roche Revenue in Biomarker-based Immunoassay Business (US$ Million), 2021–2026

Table 61. Roche Recent Development

Table 62. Abbott Company Details

Table 63. Abbott Business Overview

Table 64. Abbott Biomarker-based Immunoassay Product

Table 65. Abbott Revenue in Biomarker-based Immunoassay Business (US$ Million), 2021–2026

Table 66. Abbott Recent Development

Table 67. Danaher Company Details

Table 68. Danaher Business Overview

Table 69. Danaher Biomarker-based Immunoassay Product

Table 70. Danaher Revenue in Biomarker-based Immunoassay Business (US$ Million), 2021–2026

Table 71. Danaher Recent Development

Table 72. Siemens Healthineers Company Details

Table 73. Siemens Healthineers Business Overview

Table 74. Siemens Healthineers Biomarker-based Immunoassay Product

Table 75. Siemens Healthineers Revenue in Biomarker-based Immunoassay Business (US$ Million), 2021–2026

Table 76. Siemens Healthineers Recent Development

Table 77. Thermo Fisher Scientific Company Details

Table 78. Thermo Fisher Scientific Business Overview

Table 79. Thermo Fisher Scientific Biomarker-based Immunoassay Product

Table 80. Thermo Fisher Scientific Revenue in Biomarker-based Immunoassay Business (US$ Million), 2021–2026

Table 81. Thermo Fisher Scientific Recent Development

Table 82. Sysmex Company Details

Table 83. Sysmex Business Overview

Table 84. Sysmex Biomarker-based Immunoassay Product

Table 85. Sysmex Revenue in Biomarker-based Immunoassay Business (US$ Million), 2021–2026

Table 86. Sysmex Recent Development

Table 87. BioMerieux Company Details

Table 88. BioMerieux Business Overview

Table 89. BioMerieux Biomarker-based Immunoassay Product

Table 90. BioMerieux Revenue in Biomarker-based Immunoassay Business (US$ Million), 2021–2026

Table 91. BioMerieux Recent Development

Table 92. QuidelOrtho Company Details

Table 93. QuidelOrtho Business Overview

Table 94. QuidelOrtho Biomarker-based Immunoassay Product

Table 95. QuidelOrtho Revenue in Biomarker-based Immunoassay Business (US$ Million), 2021–2026

Table 96. QuidelOrtho Recent Development

Table 97. Becton Dickinson Company Details

Table 98. Becton Dickinson Business Overview

Table 99. Becton Dickinson Biomarker-based Immunoassay Product

Table 100. Becton Dickinson Revenue in Biomarker-based Immunoassay Business (US$ Million), 2021–2026

Table 101. Becton Dickinson Recent Development

Table 102. Bio-Rad Laboratories Company Details

Table 103. Bio-Rad Laboratories Business Overview

Table 104. Bio-Rad Laboratories Biomarker-based Immunoassay Product

Table 105. Bio-Rad Laboratories Revenue in Biomarker-based Immunoassay Business (US$ Million), 2021–2026

Table 106. Bio-Rad Laboratories Recent Development

Table 107. Qiagen Company Details

Table 108. Qiagen Business Overview

Table 109. Qiagen Biomarker-based Immunoassay Product

Table 110. Qiagen Revenue in Biomarker-based Immunoassay Business (US$ Million), 2021–2026

Table 111. Qiagen Recent Development

Table 112. Wuhan Easy Diagnosis Company Details

Table 113. Wuhan Easy Diagnosis Business Overview

Table 114. Wuhan Easy Diagnosis Biomarker-based Immunoassay Product

Table 115. Wuhan Easy Diagnosis Revenue in Biomarker-based Immunoassay Business (US$ Million), 2021–2026

Table 116. Wuhan Easy Diagnosis Recent Development

Table 117. Wondfo Company Details

Table 118. Wondfo Business Overview

Table 119. Wondfo Biomarker-based Immunoassay Product

Table 120. Wondfo Revenue in Biomarker-based Immunoassay Business (US$ Million), 2021–2026

Table 121. Wondfo Recent Development

Table 122. KHB Company Details

Table 123. KHB Business Overview

Table 124. KHB Biomarker-based Immunoassay Product

Table 125. KHB Revenue in Biomarker-based Immunoassay Business (US$ Million), 2021–2026

Table 126. KHB Recent Development

Table 127. Mindray Company Details

Table 128. Mindray Business Overview

Table 129. Mindray Biomarker-based Immunoassay Product

Table 130. Mindray Revenue in Biomarker-based Immunoassay Business (US$ Million), 2021–2026

Table 131. Mindray Recent Development

Table 132. Getein Biotech Company Details

Table 133. Getein Biotech Business Overview

Table 134. Getein Biotech Biomarker-based Immunoassay Product

Table 135. Getein Biotech Revenue in Biomarker-based Immunoassay Business (US$ Million), 2021–2026

Table 136. Getein Biotech Recent Development

Table 137. Daan Gene Company Details

Table 138. Daan Gene Business Overview

Table 139. Daan Gene Biomarker-based Immunoassay Product

Table 140. Daan Gene Revenue in Biomarker-based Immunoassay Business (US$ Million), 2021–2026

Table 141. Daan Gene Recent Development

Table 142. Research Programs/Design for This Report

Table 143. Key Data Information from Secondary Sources

Table 144. Key Data Information from Primary Sources

Table 145. Authors List of This Report

List of Figures

Figure 1. Biomarker-based Immunoassay Picture

Figure 2. Global Biomarker-based Immunoassay Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Biomarker-based Immunoassay Market Share by Type: 2025 vs 2032

Figure 4. Reagents & Kits Features

Figure 5. Instruments/Analyzers Features

Figure 6. Others Features

Figure 7. Global Biomarker-based Immunoassay Market Size Comparison by Sample (US$ Million), 2021–2032

Figure 8. Blood Features

Figure 9. Tissue Features

Figure 10. Urine Features

Figure 11. Others Features

Figure 12. Global Biomarker-based Immunoassay Market Size Comparison by Disease (US$ Million), 2021–2032

Figure 13. Cancer Features

Figure 14. Cardiovascular Features

Figure 15. Neurological Features

Figure 16. Others Features

Figure 17. Global Biomarker-based Immunoassay Market Size by Application (US$ Million), 2021–2032

Figure 18. Global Biomarker-based Immunoassay Market Share by Application: 2025 vs 2032

Figure 19. Hospital Case Studies

Figure 20. Third-party Laboratory Case Studies

Figure 21. Other Case Studies

Figure 22. Biomarker-based Immunoassay Report Years Considered

Figure 23. Global Biomarker-based Immunoassay Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 24. Global Biomarker-based Immunoassay Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 25. Global Biomarker-based Immunoassay Market Share by Region: 2025 vs 2032

Figure 26. Global Biomarker-based Immunoassay Market Share by Players in 2025

Figure 27. Global Biomarker-based Immunoassay Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 28. The Top 10 and 5 Players Market Share by Biomarker-based Immunoassay Revenue in 2025

Figure 29. North America Biomarker-based Immunoassay Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. North America Biomarker-based Immunoassay Market Share by Country (2021–2032)

Figure 31. United States Biomarker-based Immunoassay Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Canada Biomarker-based Immunoassay Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Europe Biomarker-based Immunoassay Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Europe Biomarker-based Immunoassay Market Share by Country (2021–2032)

Figure 35. Germany Biomarker-based Immunoassay Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. France Biomarker-based Immunoassay Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. U.K. Biomarker-based Immunoassay Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Italy Biomarker-based Immunoassay Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Russia Biomarker-based Immunoassay Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Ireland Biomarker-based Immunoassay Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Asia-Pacific Biomarker-based Immunoassay Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Asia-Pacific Biomarker-based Immunoassay Market Share by Region (2021–2032)

Figure 43. China Biomarker-based Immunoassay Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Japan Biomarker-based Immunoassay Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. South Korea Biomarker-based Immunoassay Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Southeast Asia Biomarker-based Immunoassay Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. India Biomarker-based Immunoassay Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Australia & New Zealand Biomarker-based Immunoassay Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Latin America Biomarker-based Immunoassay Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Latin America Biomarker-based Immunoassay Market Share by Country (2021–2032)

Figure 51. Mexico Biomarker-based Immunoassay Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Brazil Biomarker-based Immunoassay Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. Middle East & Africa Biomarker-based Immunoassay Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. Middle East & Africa Biomarker-based Immunoassay Market Share by Country (2021–2032)

Figure 55. Israel Biomarker-based Immunoassay Market Size YoY Growth (US$ Million), 2021–2032

Figure 56. Saudi Arabia Biomarker-based Immunoassay Market Size YoY Growth (US$ Million), 2021–2032

Figure 57. UAE Biomarker-based Immunoassay Market Size YoY Growth (US$ Million), 2021–2032

Figure 58. Roche Revenue Growth Rate in Biomarker-based Immunoassay Business (2021–2026)

Figure 59. Abbott Revenue Growth Rate in Biomarker-based Immunoassay Business (2021–2026)

Figure 60. Danaher Revenue Growth Rate in Biomarker-based Immunoassay Business (2021–2026)

Figure 61. Siemens Healthineers Revenue Growth Rate in Biomarker-based Immunoassay Business (2021–2026)

Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Biomarker-based Immunoassay Business (2021–2026)

Figure 63. Sysmex Revenue Growth Rate in Biomarker-based Immunoassay Business (2021–2026)

Figure 64. BioMerieux Revenue Growth Rate in Biomarker-based Immunoassay Business (2021–2026)

Figure 65. QuidelOrtho Revenue Growth Rate in Biomarker-based Immunoassay Business (2021–2026)

Figure 66. Becton Dickinson Revenue Growth Rate in Biomarker-based Immunoassay Business (2021–2026)

Figure 67. Bio-Rad Laboratories Revenue Growth Rate in Biomarker-based Immunoassay Business (2021–2026)

Figure 68. Qiagen Revenue Growth Rate in Biomarker-based Immunoassay Business (2021–2026)

Figure 69. Wuhan Easy Diagnosis Revenue Growth Rate in Biomarker-based Immunoassay Business (2021–2026)

Figure 70. Wondfo Revenue Growth Rate in Biomarker-based Immunoassay Business (2021–2026)

Figure 71. KHB Revenue Growth Rate in Biomarker-based Immunoassay Business (2021–2026)

Figure 72. Mindray Revenue Growth Rate in Biomarker-based Immunoassay Business (2021–2026)

Figure 73. Getein Biotech Revenue Growth Rate in Biomarker-based Immunoassay Business (2021–2026)

Figure 74. Daan Gene Revenue Growth Rate in Biomarker-based Immunoassay Business (2021–2026)

Figure 75. Bottom-up and Top-down Approaches for This Report

Figure 76. Data Triangulation

Figure 77. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions